Operating
Change in Other Liabilities
Amgen Change in Other Liabilities decreased by 660.0% to -$76.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Change in Other Liabilities shows a downward trend with a -24.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
A decrease indicates the company is paying down its miscellaneous obligations, which is a use of cash.
Detailed definition
This reflects the net change in various short-term and long-term obligations, such as deferred revenue, accrued expenses...
Peer comparison
For companies with large subscription or service businesses, changes in deferred revenue (a component here) are a key indicator of future growth.
Metric ID:
cf_change_in_other_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $402.00M | $99.00M | $137.00M | -$396.00M | $440.00M | $419.00M | $298.00M | -$710.00M | $1.11B | -$68.00M | $397.00M | -$56.00M | $23.00M | -$39.00M | -$78.00M | $8.00M | -$10.00M | -$76.00M |
| QoQ Change | — | -75.4% | +38.4% | -389.1% | +211.1% | -4.8% | -28.9% | -338.3% | +256.6% | -106.1% | +683.8% | -114.1% | +141.1% | -269.6% | -100.0% | +110.3% | -225.0% | -660.0% |
| YoY Change | — | — | — | — | +9.5% | +323.2% | +117.5% | -79.3% | +152.7% | -116.2% | +33.2% | +92.1% | -97.9% | +42.6% | -39.3% | -65.2% | +74.4% | — |
Range-$710.00M – $1.11B
CAGR-32.4%
Avg YoY Growth+34.4%
Median YoY Growth+33.2%
Current Streak2 quarters decline
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Amgen's change in other liabilities?
- Amgen (AMGN) reported change in other liabilities of -$76.00M in Q4 2025.
- What is the long-term trend for Amgen's change in other liabilities?
- Over 3 years (2021 to 2025), Amgen's change in other liabilities has grown at a -24.0% compound annual growth rate (CAGR), from $356.00M to -$156.00M.
- What does change in other liabilities mean?
- The change in miscellaneous debts and obligations the company owes to others.